News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
145,420 Results
Type
Article (9048)
Company Profile (61)
Press Release (136311)
Multimedia
Podcasts (12)
Webinars (2)
Section
Business (41972)
Career Advice (114)
Deals (6535)
Drug Delivery (12)
Drug Development (26766)
Employer Resources (15)
FDA (3860)
Job Trends (3903)
News (77354)
Policy (5803)
Tag
Academia (487)
Accelerated approval (1)
Adcomms (10)
Allergies (8)
Alliances (12468)
ALS (11)
Alzheimer's disease (206)
Antibody-drug conjugate (ADC) (112)
Approvals (3905)
Artificial intelligence (91)
Autoimmune disease (5)
Automation (2)
Bankruptcy (59)
Best Places to Work (3610)
BIOSECURE Act (1)
Biosimilars (36)
Biotechnology (53)
Bladder cancer (66)
Brain cancer (23)
Breast cancer (220)
Cancer (1732)
Cardiovascular disease (22)
Career advice (101)
Career pathing (3)
CAR-T (78)
Cell therapy (177)
Cervical cancer (13)
Clinical research (22307)
Collaboration (368)
Company closure (1)
Compensation (115)
Complete response letters (1)
COVID-19 (486)
CRISPR (12)
C-suite (95)
Cystic fibrosis (24)
Data (910)
Decentralized trials (1)
Depression (9)
Diabetes (31)
Diagnostics (1438)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (46)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (7)
Earnings (14647)
Editorial (9)
Employer branding (2)
Employer resources (15)
Events (25716)
Executive appointments (244)
FDA (4263)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (182)
Gene editing (21)
Generative AI (9)
Gene therapy (65)
GLP-1 (107)
Government (782)
Guidances (37)
Healthcare (4527)
Huntington's disease (2)
IgA nephropathy (7)
Immunology and inflammation (41)
Indications (15)
Infectious disease (511)
Inflammatory bowel disease (33)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (29)
Interviews (20)
IPO (3223)
IRA (7)
Job creations (522)
Job search strategy (85)
Kidney cancer (11)
Labor market (3)
Layoffs (128)
Leadership (4)
Legal (569)
Liver cancer (42)
Lung cancer (277)
Lymphoma (102)
Machine learning (3)
Management (5)
Manufacturing (50)
MASH (8)
Medical device (1577)
Medtech (1577)
Mergers & acquisitions (3458)
Metabolic disorders (75)
Multiple sclerosis (20)
NASH (2)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (305)
NextGen: Class of 2025 (1096)
Non-profit (564)
Now hiring (7)
Obesity (34)
Opinion (39)
Ovarian cancer (63)
Pain (10)
Pancreatic cancer (58)
Parkinson's disease (22)
Partnered (3)
Patents (50)
Patient recruitment (40)
Peanut (5)
People (13808)
Pharmaceutical (14)
Pharmacy benefit managers (1)
Phase I (8261)
Phase II (9374)
Phase III (7235)
Pipeline (514)
Policy (18)
Postmarket research (545)
Preclinical (2773)
Press Release (2)
Prostate cancer (80)
Psychedelics (3)
Radiopharmaceuticals (167)
Rare diseases (91)
Real estate (825)
Recruiting (6)
Regulatory (5032)
Reports (10)
Research institute (770)
Resumes & cover letters (12)
RNA editing (1)
RSV (10)
Schizophrenia (18)
Series A (38)
Series B (13)
Service/supplier (1)
Sickle cell disease (20)
Special edition (1)
Spinal muscular atrophy (16)
Sponsored (3)
Startups (825)
State (1)
Stomach cancer (10)
Supply chain (11)
Tariffs (4)
The Weekly (12)
Vaccines (154)
Venture capitalists (13)
Weight loss (18)
Women's health (1)
Date
Today (41)
Last 7 days (274)
Last 30 days (979)
Last 365 days (9661)
2025 (3525)
2024 (10432)
2023 (11749)
2022 (15261)
2021 (15317)
2020 (12946)
2019 (9830)
2018 (7329)
2017 (8179)
2016 (7350)
2015 (8058)
2014 (5367)
2013 (3826)
2012 (4053)
2011 (4193)
2010 (3645)
Location
Africa (100)
Alabama (21)
Alaska (2)
Arizona (21)
Arkansas (2)
Asia (11709)
Australia (1651)
California (1910)
Canada (489)
China (294)
Colorado (54)
Connecticut (81)
Delaware (117)
Europe (22497)
Florida (245)
Georgia (11)
Idaho (8)
Illinois (174)
India (9)
Indiana (60)
Iowa (3)
Japan (82)
Kansas (8)
Kentucky (10)
Maine (3)
Maryland (239)
Massachusetts (1571)
Michigan (20)
Minnesota (79)
Missouri (6)
Montana (5)
Nebraska (2)
Nevada (10)
New Hampshire (7)
New Jersey (548)
New Mexico (4)
New York (497)
North Carolina (229)
Northern California (947)
Ohio (49)
Oklahoma (1)
Oregon (5)
Pennsylvania (333)
Rhode Island (5)
South America (137)
South Carolina (3)
Southern California (721)
Tennessee (15)
Texas (311)
United States (6756)
Utah (51)
Virginia (22)
Washington D.C. (5)
Washington State (188)
Wisconsin (17)
145,420 Results for "surface oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CardioVia Announces FDA Clearance for ViaOne, Opening a New Frontier in Minimally Invasive Heart-Surface Treatments
April 8, 2025
·
2 min read
Deals
Coherus Completes Surface Oncology Acquisition
Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the closing of the previously announced acquisition of Surface Oncology, Inc.
September 8, 2023
·
7 min read
Business
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
Surface Oncology today reported financial results and corporate highlights for the second quarter 2023.
August 2, 2023
·
15 min read
Genetown
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
Surface Oncology, Inc. announced that both Institutional Shareholder Services and Glass, Lewis & Co. have recommended Surface stockholders vote “FOR” the adoption of Surface’s merger agreement with Coherus BioSciences, Inc.
August 31, 2023
·
16 min read
Press Releases
Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications
April 1, 2025
·
4 min read
Business
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
Surface Oncology today reported financial results and corporate highlights for the first quarter 2023, as well as anticipated near-term milestones.
May 4, 2023
·
8 min read
Press Releases
Kura Oncology to Participate in Stifel Targeted Oncology Forum
April 1, 2025
·
2 min read
Press Releases
Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
May 7, 2025
·
5 min read
Genetown
Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference
Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the 2023 Guggenheim Oncology Days conference in New York City on Thursday, February 9, 2023, at 1:35 p.m. ET.
February 2, 2023
·
1 min read
BioMidwest
Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System
Accuray Incorporated (NASDAQ: ARAY) announced today that the company has initiated sales of the VitalHold™* package supporting surface-guided radiation therapy (SGRT) on the Radixact ® System in Japan beginning November 30, 2023.
December 5, 2023
·
5 min read
1 of 14,542
Next
